The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | N | Nervous system | |
| 2 | N04 | Anti-parkinson drugs | |
| 3 | N04B | Dopaminergic agents | |
| 4 | N04BB | Adamantane derivatives |
| Code | Title | |
|---|---|---|
| N04BB01 | Amantadine |
| Active Ingredient | Description | |
|---|---|---|
| Amantadine |
Amantadine has been shown to be a low affinity antagonist at the N-methyl-D-aspartate (NMDA) subtype of glutamate receptors. Overactivity of glutamatergic neurotransmission has been implicated in the generation of parkinsonian symptoms. In addition, amantadine specifically inhibits the replication of influenza A viruses at low concentrations. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| Symmetrel Capsules | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
